Skip to content

Tyverb 250 mg film-coated tablets

DRUG2 trials

Sponsors

Universitair Medisch Centrum Utrecht, Institut National De La Sante Et De La Recherche Medicale

Conditions

Unresectable locally advanced and/or metastatic soft-tissue sarcomametastatic colorectal cancer with a proven RAS mutation after failure of standard systemic treatment regimens including at least 5- FU/capecitabine-oxaliplatin and irinotecan based standard treatment (unless contra-indications for either oxaliplatin or irinotecan)